Best Oncologist Long Beach Near Me

4worldlovers: Dr. Nilesh L. Vora is a board-certified hematologist and medical oncologist and serves as medical director of the MemorialCare Todd Cancer Institute at Long Beach Medical Center. He also serves as Chair of Hematology and Medical Oncology for the MemorialCare Medical Foundation.

Dr. Vora graduated from Keck School of Medicine, University of Southern California as a Dean’s Scholar and class president. He completed his residency at Harbor - UCLA Medical Center and a fellowship in hematology and medical oncology at The City of Hope. Dr. Vora is board-certified in Hematology & Medical Oncology and Hospice & Palliative Medicine.

He is a generalist with a specialized interest in lung cancer; gastrointestinal cancers including colorectal, pancreatic and gastric; and malignant hematology disorders. In addition to his clinical work, Dr. Vora has led and is currently involved in the clinical trial offerings at the MemorialCare Todd Cancer Institute.

Dr. Vora serves as a cancer liaison physician for the American College of Surgeons (ACS). He is an active member of American College of Physicians (ACP), American Society of Clinical Oncologists (ASSO) and the American Society of Hematology (ASH). In addition, he was recognized as a Top Los Angeles Doctor by the Los Angeles Business Journal in 2022.

In his free time, Dr. Vora enjoys being a leader for his wonderful wife, and three beautiful kids. He has a passion for exercise and staying in shape and has made Orangetheory Fitness his side job. He lives by the motto-- "live life well-- one day at a time".

4worldlovers: We analyze your living cancer cells to find out the drugs, combinations, and sequences that are most effective.

We match your results with more than 10,000 patient studies to ensure you have the most likely treatment to be effective against your specific cancer.


This approach reduces the guesswork from drug selection to find the most effective, least toxic options. Results only take 7 days.


You and your doctor can then use this information to guide your treatment.


Ex Vivo Best Regimen Provides A 2.04 Fold Higher Response and 1.44 Fold Higher One-Year Survival*


We do not use 3D organoids or anything except the patient's own cells to test.


This process reduces the guesswork and gives you the information you and your oncologist need to help you make a truly informed decision about your treatment with the best available data.


* An Explant is a portion of tumor that has been maintained in tissue culture without disrupting the architecture or structure of the cancer cell micro-environment. Unlike cultured “3-D Organoids” Explants are never grown or amplified. This preserves their validity for clinical response prediction.


Dr. Robert Nagourney is an internationally recognized pioneer in cancer research and personalized cancer treatment.

With more than 20 years of experience in human tumor primary culture analyses, Dr. Nagourney has authored more than 100 manuscripts and abstracts including publications in the Journal of Clinical Oncology, Gynecologic Oncology, and the Journal of the National Cancer Institute.

Over the past 20+ years, Dr. Nagourney and his team at the Nagourney Cancer Institute have developed a laboratory technique, functional profiling, that measures how cancer cells respond when they are exposed to a wide variety of drugs and drug combinations.

By using this approach, the Nagourney team can determine the best drugs for each patient before they receive them. This reduces the guesswork in selecting the right drug treatment for you and is why our analysis is more powerful than genomic testing offered by most centers.

We analyze your living cancer cells to find out the drugs, combinations, and sequences that are most effective for you. This reduces the guesswork in selecting your cancer treatment by measuring how your cancer cells will respond to drugs before you receive treatment.

This helps select the most effective and least toxic drug regimen for your cancer.